Chengkai Wu

No. 55 Zhenhai Road, Xiamenwuuker@163.com

A researcher specializing in chronic disease epidemiology, metabolic disorders, and artificial intelligence-assisted disease prediction. His research focuses on chronic kidney disease (CKD), hyperuricemia, metabolic syndrome, obesity-related metabolic abnormalities, and non-alcoholic fatty liver disease. He has extensive experience in population-based cohort studies, particularly using large-scale datasets such as the UK Biobank, to investigate disease risk factors, clinical outcomes, and prognostic indicators. Research integrates epidemiological approaches with machine learning and multimodal data analysis to identify early diagnostic markers and improve risk stratification. His work has been published in peer-reviewed journals, including *Advanced Science*, *Frontiers in Nutrition*, *BMC Nephrology*, and *BMC Gastroenterology*. His broader research interests include the interplay between lifestyle factors, metabolic health, and chronic disease progression, with an emphasis on translating epidemiological findings into precision prevention and personalized healthcare.

PublicationsPublications

  1. Wu, C., Pan, C., Liu, L., & Li, W. (2026). Association between weight-adjusted waist index and risk of mortality and disease progression in participants with chronic kidney disease: a prospective study from the UK Biobank. Frontiers in Nutrition, 13, 1646414–1646414. https://doi.org/10.3389/fnut.2026.1646414
    CiteBibTeX RIS CSL-JSON
    PubMed
    Abstract

    Background The weight-adjusted waist index (WWI), a novel metric reflecting central obesity, has shown potential as a predictor of adverse health outcomes. This study investigated the associations between WWI and all-cause mortality, cardiovascular disease (CVD) mortality, and the incidence of end-stage kidney disease (ESKD) among participants with chronic kidney disease (CKD), and further compared its predictive performance with that of conventional obesity indices. Methods This prospective cohort study was conducted with data from the United Kingdom Biobank (UKB). Participants with CKD at baseline were included, while those with ESKD, missing data on WWI or other obesity indicators, or incomplete covariate information were excluded. Follow-up time was calculated from the baseline to the occurrence of disease diagnoses, surgical interventions, mortality or the censoring date (31 December 2021). CKD was diagnosed using baseline clinical data, and WWI was calculated as the waist circumference (WC, cm) divided by the square root of body weight (kg). Cox proportional hazards models and restricted cubic spline (RCS) analysis were employed to examine the associations between WWI and all outcomes. Receiver operating characteristic (ROC) curve analysis were conducted to compare the predictive performance of WWI, body mass index (BMI) and WC. Results During a follow-up period of 269,858.2 person-years for 22,523 participants, 3,874 all-cause deaths, 786 CVD deaths and 823 ESKD events were recorded. WWI exhibited non-linear association with all-cause mortality and ESKD incidence ( P for non-linear < 0.001), and linear association with CVD mortality ( P for non-linear = 0.175). WWI values above the threshold (10.5 cm/√kg) showed significant positive associations with all outcomes (all P value < 0.001). WWI demonstrated superior overall predictive performance compared with traditional obesity indicators, particularly in predicting all-cause mortality. Conclusion These findings suggest that an elevated WWI is associated with an increased risk of all-cause mortality, CVD mortality and ESKD in patients with CKD, particularly in high WWI groups. Although WWI demonstrated statistically superior discriminatory performance compared with BMI and WC, its overall discriminative capacity remained modest. Accordingly, WWI may serve as a complementary anthropometric indicator for risk assessment in CKD, further studies are required to establish its clinical applicability.

  2. Wu, C., Pan, C., Liu, L., & Li, W. (2025). Association of metabolic syndrome and hyperuricemia with mortality in patients with chronic kidney disease: a UK biobank study. BMC Nephrology, 26(1), 696–696. https://doi.org/10.1186/s12882-025-04615-0
    CiteBibTeX RIS CSL-JSON
    PubMed
    Abstract

    BACKGROUND: Chronic kidney disease (CKD) has detrimental effects on health through multiple pathophysiological mechanisms, significantly reducing life expectancy and contributing to a substantial disease burden. Therefore, this study aims to explore the association of metabolic syndrome (MetS) and hyperuricemia (HUA) with all-cause and cardiovascular mortality in patients with chronic kidney disease (CKD). METHODS: or urine albumin creatinine ratio > 3 mg/mmol, MetS (≥ 3 of 5 criteria), and HUA (> 7.0 mg/dL in males, > 6.0 mg/dL in females) were assessed. The outcomes included all-cause and cardiovascular mortality. Associations were assessed using multivariate-adjusted Cox proportional hazards models and Kaplan-Meier survival analysis, supplemented by subgroup analyses and sensitivity tests. RESULTS: During a median follow-up of 13.21 years, 3564 all-cause deaths (17.28%) were recorded, including 1025 (4.97%) attributable to cardiovascular causes. After multiple adjustments, both HUA and MetS were strongly associated with all-cause and cardiovascular mortality. Patients with CKD and coexisting HUA or MetS exhibited a significantly higher risk of all-cause mortality (adjusted hazard ratio [aHR] = 1.45, 95% confidence interval [CI]: 1.30-1.62) and cardiovascular mortality (aHR = 2.09, 95% CI: 1.70-2.58) than those without HUA or MetS. Kaplan-Meier curves demonstrated that elevated uric acid levels and a high number of MetS components significantly reduced survival probability (P < 0.001), with an increasing trend as the uric acid levels and the number of MetS components increased. Subgroup and sensitivity analyses confirmed the robustness and consistency of our findings. CONCLUSION: MetS and HUA significantly increased all-cause and cardiovascular mortality in patients with CKD, particularly in those with high uric acid levels and a high number of MetS components. CLINICAL TRIAL NUMBER: Not applicable.

  3. Xiao, L., Zeng, L., Wang, J., Hong, C., Zhang, Z., Wu, C., Cui, H., Li, Y., Li, R., Liang, S., Deng, Q., Li, W., Zou, X., Ma, P., & Liu, L. (2025). Development and Validation of Machine Learning‐Based Marker for Early Detection and Prognosis Stratification of Nonalcoholic Fatty Liver Disease. Advanced Science, 12(33), e10527–e10527. https://doi.org/10.1002/advs.202410527
    CiteBibTeX RIS CSL-JSON
    PubMed
    Abstract

    Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease and is considered the hepatic manifestation of metabolic syndrome, triggering out adverse outcomes. A stacked multimodal machine learning model is constructed and validated for early identification and prognosis stratification of NAFLD by integrating genetic and clinical data sourced from 36 490 UK Biobank and 9 007 Nanfang Hospital participants and extracted its probabilities as in-silico scores for NAFLD (ISNLD). The efficacy of ISNLD is evaluated for the early prediction of severe liver disease (SeLD) and analyzed its association with metabolism-related outcomes. The multimodal model performs satisfactorily in classifying individuals into low- and high-risk groups for NAFLD, achieving area under curves (AUCs) of 0.843, 0.840, and 0.872 within training, internal, and external test sets, respectively. Among high-risk group, ISNLD is significantly associated with intrahepatic and metabolism-related complications after lifestyle factors adjustment. Further, ISNLD demonstrates notable capability for early prediction of SeLD and further stratifies high-risk subjects into three risk subgroups of elevated risk for adverse outcomes. The findings emphasize the model's ability to integrate multimodal features to generate ISNLD, enabling early detection and prognostic prediction of NAFLD. This facilitates personalized stratification for NAFLD and metabolism-related outcomes based on digital non-invasive markers, enabling preventive interventions.

  4. Liu, Y., Xing, Z., Wu, B., Chen, N., Wu, T., Cai, Z., Guo, D., Tao, G., Xie, Z., Wu, C., Cao, P., Wang, X., & Li, J. (2024). Association of MRI-based knee osteoarthritis structural phenotypes with short-term structural progression and subsequent total knee replacement. Journal of Orthopaedic Surgery and Research, 19(1), 699–699. https://doi.org/10.1186/s13018-024-05194-w
    CiteBibTeX RIS CSL-JSON
    PubMed
    Abstract

    BACKGROUND: The failure of disease-modifying osteoarthritis drugs (DMOADs) trials lies mainly in the heterogeneity of the disease, which calls for a more precise population with specific progression and outcomes. This study aimed to determine whether and which MRI-based structural phenotype of knee osteoarthritis (KOA) is associated with short-term structural progression and subsequent total knee replacement (TKR). METHODS: A longitudinal study was conducted among participants with baseline Kellgren-Lawrence grade (KLG) ≥ 2 from the Osteoarthritis Initiative (OAI). The structural phenotypes at baseline were defined as subchondral bone, meniscus/cartilage and inflammatory phenotypes according to the MRI Osteoarthritis Knee Score (MOAKS). The primary outcome was the progression of structural abnormalities within 24 months and multivariable logistic regressions were applied to evaluate the associations. The secondary outcome was the incidence of TKR during 108 months. Cox regressions and Kaplan-Meier survival curves were used for the analysis. RESULTS: A total of 733 participants with KOA were finally included in our study, with 493 (67.3%) having the three main structural phenotypes. For the primary outcome, the subchondral bone phenotype (OR [95% CI]:1.71 [1.02, 2.83], 1.52 [1.06, 2.18], 1.65 [1.11, 2.42], respectively) and the inflammatory phenotype (OR [95% CI]: 1.69 [1.05, 2.74], 1.82 [1.31, 2.52], 2.15 [1.48, 3.14], respectively) were both associated with the short-term progression of joint space narrowing, osteophytes and sclerosis in 24 months, whereas the meniscus/cartilage phenotype was only associated with the progression of osteophytes and sclerosis. For the secondary outcome, the subchondral bone phenotype (HR [95% CI]: 1.71 [1.06-2.78]) and inflammatory phenotype (HR [95%CI]: 2.00 [1.02-2.67]) were associated with shorter time to subsequent TKR, but not the meniscus/cartilage phenotype. Besides, the cumulative effect when the structural phenotype overlapped was confirmed in both outcomes. CONCLUSIONS: The subchondral bone phenotype and inflammatory phenotype were associated with the progression of joint space narrowing, osteophytes and sclerosis in 24 months, along with subsequent TKR in 108 months. Besides, additive effects of overlapped phenotypes were further determined. These phenotypes could serve as valuable screening tools for future clinical trials and provide guidance for risk evaluation.

  5. Zeng, L., Ma, P., Li, Z., Liang, S., Wu, C., Hong, C., Li, Y., Cui, H., Li, R., Wang, J., He, J., Li, W., Xiao, L., & Liu, L. (2024). Multimodal Machine Learning‐Based Marker Enables Early Detection and Prognosis Prediction for Hyperuricemia. Advanced Science, 11(34), e2404047–e2404047. https://doi.org/10.1002/advs.202404047
    CiteBibTeX RIS CSL-JSON
    PubMed
    Abstract

    Hyperuricemia (HUA) has emerged as the second most prevalent metabolic disorder characterized by prolonged and asymptomatic period, triggering gout and metabolism-related outcomes. Early detection and prognosis prediction for HUA and gout are crucial for pre-emptive interventions. Integrating genetic and clinical data from 421287 UK Biobank and 8900 Nanfang Hospital participants, a stacked multimodal machine learning model is developed and validated to synthesize its probabilities as an in-silico quantitative marker for hyperuricemia (ISHUA). The model demonstrates satisfactory performance in detecting HUA, exhibiting area under the curves (AUCs) of 0.859, 0.836, and 0.779 within the train, internal, and external test sets, respectively. ISHUA is significantly associated with gout and metabolism-related outcomes, effectively classifying individuals into low- and high-risk groups for gout in the train (AUC, 0.815) and internal test (AUC, 0.814) sets. The high-risk group shows increased susceptibility to metabolism-related outcomes, and participants with intermediate or favorable lifestyle profiles have hazard ratios of 0.75 and 0.53 for gout compared with those with unfavorable lifestyles. Similar trends are observed for other metabolism-related outcomes. The multimodal machine learning-based ISHUA marker enables personalized risk stratification for gout and metabolism-related outcomes, and it is unveiled that lifestyle changes can ameliorate these outcomes within high-risk group, providing guidance for preventive interventions.

  6. Hong, C., Wu, C., Ma, P., Cui, H., Chen, L., Li, R., Li, Q., Zeng, L., Liao, S., Xiao, L., Liu, L., & Li, W. (2022). Positive association of nap duration with risk of non-alcoholic fatty liver disease in an occupational population in Guangdong Province, China: a cross-sectional study. BMC Gastroenterology, 22(1), 185–185. https://doi.org/10.1186/s12876-022-02246-5
    CiteBibTeX RIS CSL-JSON
    PubMed
    Abstract

    BACKGROUND: A lack of sleep or disorder in sleep-wake cycles has been associated with metabolic impairments. However, few studies have investigated the association between daytime napping duration and the risk of non-alcoholic fatty liver disease. This study aimed to investigate the association of daytime napping duration with the risk of non-alcoholic fatty liver disease in a Chinese population. METHODS: This cross-sectional study analyzed data from the Health Management Center of Nanfang Hospital, Guangdong Province. A total of 3363 participants aged 20-79 years were recruited and admitted from January 20, 2018, to October 16, 2020. Non-alcoholic fatty liver disease was diagnosed using abdominal ultrasonography. The outcome was the association between daytime sleep duration and the risk of non-alcoholic fatty liver disease. RESULTS: Compared with non-nappers, long daytime nappers (≥ 60 min) were associated with a higher risk of non-alcoholic fatty liver disease in the crude model (odds ratio 2.138; 95% confidence interval 1.88-2.61, P < 0.05) and in the multivariable adjustment model (odds ratio 2.211; 95% confidence interval 1.042-4.690, P < 0.05) after adjusting for demographic, educational, and metabolic risk factors. The association was moderately enhanced with additional adjustments for night sleep duration and socioeconomic or other factors (odds ratio 2.253; 95% confidence interval 1.061-4.786, P = 0.035). CONCLUSION: In this cross-sectional study, daytime napping duration of ≥ 60 min was positively associated with the risk of non-alcoholic fatty liver disease in an occupational population of Guangdong Province after multivariable adjustment.

  7. Li, Q., Wu, C., Ma, P., Cui, H., Li, R., Hong, C., Zeng, L., Liao, S., Xiao, L., Liu, L., & Li, W. (2022). Breakfast consumption frequency is associated with dyslipidemia: a retrospective cohort study of a working population. Lipids in Health and Disease, 21(1), 33–33. https://doi.org/10.1186/s12944-022-01641-x
    CiteBibTeX RIS CSL-JSON
    PubMed
    Abstract

    BACKGROUND: Dyslipidemia is a significant contributor to cardiovascular and cerebrovascular diseases. Research on the relationship between breakfast consumption frequency and dyslipidemia in the working population is lacking. Therefore, we aimed to investigate this relationship based on a retrospective cohort study of a large working population in China. METHODS: This retrospective cohort study used data from the physical examinations and questionnaire survey of working participants at Nanfang Hospital from January 20, 2015 to October 16, 2020. Univariate and multivariate analyses were conducted to explore the relationship between breakfast consumption frequency and dyslipidemia in this working population (n = 7644). RESULTS: The prevalence of dyslipidemia among the participants was 26.4%. The univariate logistic regression test showed that the breakfast consumption frequency was inversely correlated with dyslipidemia. After adjusting for multiple factors, such as sex, age, body mass index, hypertension, hyperuricaemia, diabetes, smoking status, alcohol consumption, education level, marital status, long-term exposure to kitchen oil fumes, attending business dinners, and sleep time, it was found that breakfast consumption remained inversely associated with dyslipidaemia. The odds ratio for daily breakfast consumption was 0.466 (95% confidence interval 0.283-0.770, P = 0.003). After adjusting for confounding factors, we found that the higher the frequency of breakfast consumption, the lower the odds ratios for hypertriglyceridaemia. CONCLUSIONS: This study demonstrated that breakfast consumption frequency was inversely correlated with dyslipidemia. The higher the frequency of breakfast, the lower the risk of hypertriglyceridaemia. This study provides a basis on which dietary suggestions for the working population and lifestyle guidance for patients with a clinical need to prevent dyslipidemia can be made.

  8. Li, R., Zeng, L., Wu, C., Ma, P., Cui, H., Chen, L., Li, Q., Hong, C., Liu, L., Xiao, L., & Li, W. (2022). Tea Consumption is Associated with an Increased Risk of Hyperuricemia in an Occupational Population in Guangdong, China. International Journal of General Medicine, Volume 15, 2747–2757. https://doi.org/10.2147/ijgm.s355253
    CiteBibTeX RIS CSL-JSON
    PubMed
    Abstract

    Purpose: Chronic hyperuricemia leads to long-term deposition of monosodium urate crystals that may damage the joint structure and affect quality of life. Although hyperuricemia prevalence varies, most studies indicate increased cases of hyperuricemia worldwide. The relationship between hyperuricemia and tea consumption is uncertain. This cross-sectional study investigated the effect of tea consumption on the risk of hyperuricemia in the working population in Guangdong, China. Patients and Methods: Data on weight, height, blood pressure, laboratory test results, and health questionnaire responses of 7644 adults aged ≥ 18 years were obtained from the health examinee dataset of Nanfang Hospital. The characteristics of subjects with and without hyperuricemia were compared using t -tests or non-parametric Mann–Whitney U -tests for continuous variables and chi-square tests for categorical variables. Relationships between hyperuricemia and participant characteristics (sex, age, education level, smoking history, alcohol consumption, hypertension, body mass index, tea consumption, and other dietary factors) were examined using univariate and multivariate logistic regression models to identify independent risk factors for hyperuricemia. Results: Tea consumption was associated with a higher risk of hyperuricemia in the crude model (odds ratio [OR] 1.74, 95% confidence interval [CI] 1.48– 2.05, once a month through twice a week vs never, P < 0.001; OR 2.44, 95% CI 2.07– 2.89, ≥ 3 times a week vs never, P < 0.001). The adjusted OR for hyperuricemia was 1.30 (95% CI 1.08– 1.56, P =0.006) in participants who consumed tea once a month through twice a week and 1.35 (95% CI 1.11– 1.64, P =0.003) in those who consumed tea ≥ 3 times a week compared with the “never” reference group after adjusting for sociodemographic factors, anthropometric and biochemical indices, and dietary factors. This relationship remained significant in men but not women in subgroup analysis. Conclusion: Tea consumption is an independent risk factor for hyperuricemia and is more pronounced in men than women. Keywords: tea consumption, hyperuricemia, Chinese working population, risk factor

  9. Wu, C., Li, Y., Cen, T., He, Y., Pan, C., Li, J., Xie, Z., Li, W., Tung, T., & Fang, H. (2026). Association between oxidative balance score and kidney stone disease: a prospective cohort study from the UK Biobank. Nutrition Journal. https://doi.org/10.1186/s12937-026-01383-x
    CiteBibTeX RIS CSL-JSON
    Abstract

    Oxidative stress has been implicated in the development of kidney stone disease. The Oxidative Balance Score (OBS), which integrates dietary and lifestyle pro- and antioxidant exposures, provides a comprehensive measure of overall oxidative balance. This study aimed to examine the prospective associations between OBS, its dietary (DOBS) and lifestyle (LOBS) components, and kidney stone disease. This prospective study included 171,576 UK Biobank participants without a hospital diagnosis of kidney stone disease. Inverse probability of treatment weighting was used to achieve covariate balance across groups. Weighted Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs), with restricted cubic spline analyses used to examine potential non-linear associations. Subgroup analyses were performed to evaluate potential effect modification; sensitivity analyses were conducted to assess the robustness of the findings. During 2,081,286 person-years of follow-up, 1,909 incident kidney stone disease events were identified. Each 1-point increment in OBS was associated with a lower risk of kidney stone disease (HR: 0.99, 95% CI: 0.98–0.99). Participants in the highest OBS quartile had a significantly lower risk compared with those in the lowest (HR: 0.81, 95% CI: 0.71–0.93). For DOBS, compared with that in the lowest quartile, a significantly lower risk was observed only in the third quartile (HR: 0.87, 95% CI: 0.76–0.98). In contrast, LOBS demonstrated a progressively lower risk across relatively high quartiles (Q4 vs. Q1: HR: 0.59, 95% CI: 0.49–0.71). Subgroup analyses showed that the associations remained significant among men, participants aged ≤ 60 years, and those without diabetes. Sensitivity analyses yielded similar results. Relatively high OBS was associated with a lower risk of kidney stone disease. DOBS and LOBS contributed to this inverse association while exhibiting distinct association patterns. These findings provide additional epidemiological evidence regarding oxidative balance and kidney stone disease risk and highlight potential opportunities for prevention strategies targeting modifiable dietary and lifestyle factors.

Updated Nov 21, 2026 · living CV, updates automatically

SubscribeAdd this feed URL to your RSS reader: https://sigmacv.org/p/chengkai-wu-ffa8192ae35cba567575/feed.xml

Save these publications to a reference manager (Zotero, Mendeley…) — your browser connector will detect them.

Made with SigmaCV